Valerie Lund Selected Research

Rhinosinusitis

12/2023	EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care.
1/2023	European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis.
1/2023	Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
1/2022	A Comparison of International Guidelines for Rhinosinusitis.
1/2021	British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps.
1/2021	International consensus statement on allergy and rhinology: rhinosinusitis 2021.
4/2019	Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial.
2/2016	International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.
1/2016	Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.
4/2013	Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerie Lund Research Topics

Disease

14	Rhinosinusitis 12/2023 - 03/2002
9	Nasal Polyps (Nasal Polyp) 12/2023 - 01/2016
6	Hypersensitivity (Allergy) 12/2023 - 01/2006
3	Asthma (Bronchial Asthma) 12/2019 - 01/2006
2	Polyps 06/2008 - 01/2006
2	Nasal Obstruction 06/2008 - 01/2006
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2019
1	Facial Pain (Myofacial Pain) 06/2008
1	Hemorrhage 02/2006
1	Allergic Fungal Sinusitis 01/2006
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 01/2006
1	Rhinitis 01/2006
1	Allergic Rhinitis 01/2006
1	Cystic Fibrosis (Mucoviscidosis) 01/2006

Drug/Important Bio-Agent (IBA)

3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2006
3	Iron-Dextran Complex (InFed)FDA Link 01/2022 - 02/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 03/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 01/2006
2	SteroidsIBA 04/2019 - 06/2008
2	Interleukin-5 (Interleukin 5)IBA 01/2016 - 01/2006
2	Immunoglobulin E (IgE)IBA 01/2016 - 01/2006
1	mepolizumabIBA 01/2023
1	anti-IgE antibodiesIBA 12/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 04/2019
1	MacrolidesIBA 04/2019
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Enterotoxins (Enterotoxin)IBA 01/2016
1	ExotoxinsIBA 03/2010
1	ExfoliatinsIBA 03/2010
1	SuperantigensIBA 03/2010
1	Histamine Antagonists (Antihistamines)IBA 06/2008
1	SolutionsIBA 11/2006
1	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2006
1	CytokinesIBA 01/2006
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2006

Therapy/Procedure

3	Therapeutics 01/2023 - 04/2013
2	Biological Therapy 01/2021 - 12/2019
1	Precision Medicine 01/2017
1	Reoperation 02/2006